About: Adverse Drug Reactions Advisory Committee

An Entity of Type: organisation, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

The Adverse Drug Reactions Advisory Committee or ADRAC was a subcommittee of the Australian Drug Evaluation Committee (ADEC) which monitored the safety of medicines in Australia. ADRAC was replaced by the Advisory Committee on the Safety of Medicines (ACSOM) in 2010. In 2017, the Advisory Committee on Medicines (ACM) was established, consolidating the functions of the Advisory Committee on Prescription Medicines (ACPM), the Advisory Committee on the Safety of Medicines (ACSOM) and the Advisory Committee on Non-Prescription Medicines (ACNM).

Property Value
dbo:abstract
  • The Adverse Drug Reactions Advisory Committee or ADRAC was a subcommittee of the Australian Drug Evaluation Committee (ADEC) which monitored the safety of medicines in Australia. ADRAC was replaced by the Advisory Committee on the Safety of Medicines (ACSOM) in 2010. In 2017, the Advisory Committee on Medicines (ACM) was established, consolidating the functions of the Advisory Committee on Prescription Medicines (ACPM), the Advisory Committee on the Safety of Medicines (ACSOM) and the Advisory Committee on Non-Prescription Medicines (ACNM). ADRAC evaluated reports from the Adverse Drug Reactions Unit (now a function of the Pharmacovigilance Branch) of the Therapeutic Goods Administration (TGA), which administers the adverse drug reaction (ADR) reporting system in Australia, and makes recommendations regarding the medication including withdrawal of medications from the market. ADRAC also published the Australian Adverse Drug Reactions Bulletin (now Medicines Safety Update) to raise awareness of medication safety issues and ADR reports. (en)
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 2340422 (xsd:integer)
dbo:wikiPageLength
  • 2487 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1102679842 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
schema:sameAs
rdf:type
rdfs:comment
  • The Adverse Drug Reactions Advisory Committee or ADRAC was a subcommittee of the Australian Drug Evaluation Committee (ADEC) which monitored the safety of medicines in Australia. ADRAC was replaced by the Advisory Committee on the Safety of Medicines (ACSOM) in 2010. In 2017, the Advisory Committee on Medicines (ACM) was established, consolidating the functions of the Advisory Committee on Prescription Medicines (ACPM), the Advisory Committee on the Safety of Medicines (ACSOM) and the Advisory Committee on Non-Prescription Medicines (ACNM). (en)
rdfs:label
  • Adverse Drug Reactions Advisory Committee (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License